RHUMBLINE ADVISERS - GT BIOPHARMA INC ownership

GT BIOPHARMA INC's ticker is GTBP and the CUSIP is 36254L209. A total of 57 filers reported holding GT BIOPHARMA INC in Q4 2021. The put-call ratio across all filers is 2.63 and the average weighting 0.0%.

Quarter-by-quarter ownership
RHUMBLINE ADVISERS ownership history of GT BIOPHARMA INC
ValueSharesWeighting
Q1 2022$46,000
-9.8%
16,087
-3.6%
0.00%
Q4 2021$51,000
-54.5%
16,6880.0%0.00%
Q3 2021$112,000
-61.2%
16,688
-10.4%
0.00%
Q2 2021$289,00018,6340.00%
Other shareholders
GT BIOPHARMA INC shareholders Q4 2021
NameSharesValueWeighting ↓
Crumly & Associates Inc. 32,163$93,0000.04%
OCCUDO QUANTITATIVE STRATEGIES LP 20,075$58,0000.01%
SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC 28,260$81,0000.00%
Sigma Planning Corp 21,400$62,0000.00%
Compagnie Lombard Odier SCmA 30,000$86,0000.00%
Gordian Capital Singapore Pte Ltd 35,000$3,0000.00%
Welch Group, LLC 10,000$29,0000.00%
Renaissance Technologies 186,300$537,0000.00%
BRIGHTON JONES LLC 11,012$32,0000.00%
Capital Advisors, Ltd. LLC 24$00.00%
View complete list of GT BIOPHARMA INC shareholders